An iPSC-derived CD19/BCMA CAR-NK therapy in a patient with systemic sclerosis
Xiaobing Wang(Shanghai Changzheng Hospital), Yi Zhang(Shanghai Changzheng Hospital), Yi Jin(Shanghai Changzheng Hospital), Lie Dai(Sun Yat-sen University), Yanan Yue(Hangzhou DAC Biotech (China)), Jiapan Hu(Hangzhou DAC Biotech (China)), Xin Liu(Shanghai Changzheng Hospital), Kun Pang(University of Chinese Academy of Sciences), Siyuan Ye(Shanghai Changzheng Hospital), Yue Chen(Wenzhou Medical University), Wenjing Ye(Fudan University), Xiaofei Shi(First Affiliated Hospital of Henan University of Science and Technology), Xin Ma(First Affiliated Hospital of Henan University of Science and Technology), Le‐Hang Guo(Shanghai Tenth People's Hospital), Yanfang Liu(Second Military Medical University), Na Ta(Second Military Medical University), Xiaofang Zhu(Wenzhou Medical University), Lin Li(Shanghai Changzheng Hospital), Jiazheng Wang(Shanghai Changzheng Hospital), Ran Yan(Shanghai Changzheng Hospital), Ping Wang(Shanghai Changzheng Hospital), Xiaobin Song(Hangzhou DAC Biotech (China)), Yixuan Zhou(Hangzhou DAC Biotech (China)), Lina Zhou(Shanghai Changzheng Hospital), Qing Wang(Focused Photonics (China)), T. Y. Guan(Shanghai Changzheng Hospital), Ting Li(Shanghai Changzheng Hospital), Ling Zhou(Shanghai Changzheng Hospital), Weihua Pan(Shanghai Changzheng Hospital), Yanran He(University of Chicago), Xinyu Wu(Shanghai Changzheng Hospital), Yingyong Xu(Hangzhou DAC Biotech (China)), Luhan Yang(Hangzhou DAC Biotech (China)), Huji Xu(Center for Life Sciences)
Cited by 56
Abstract
Related Papers
2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative
F.H.J. van den Hoogen, Dinesh Khanna, Jaap Fransen et al.|Annals of the Rheumatic Diseases|2013|2.8k